Thrombosis Research
Volume 125, Issue 3 , Pages 239-245 , March 2010

Flow-based measurements of von Willebrand factor (VWF) function: Binding to collagen and platelet adhesion under physiological shear rate

  • Birte Fuchs

      Affiliations

    • Octapharma Research & Development, Molecular Biochemistry Department, Berlin, Germany
    • ,
  • Ulrich Budde

      Affiliations

    • AescuLabor-Hamburg, Institut der Labormedizin, Hamburg, Germany
    • ,
  • Andrea Schulz

      Affiliations

    • Institute of Chemistry and Biochemistry, Organic Chemistry, Freie Universität Berlin, Germany
    • ,
  • Craig M. Kessler

      Affiliations

    • Lombardi Cancer Center, Georgetown University Medical Center, Washington, USA
    • ,
  • Claudine Fisseau

      Affiliations

    • Octapharma Research & Development, Molecular Biochemistry Department, Berlin, Germany
    • ,
  • Christoph Kannicht

      Affiliations

    • Octapharma Research & Development, Molecular Biochemistry Department, Berlin, Germany
    • Corresponding Author InformationCorresponding author. Octapharma R&D, Molecular Biochemistry Department, Arnimallee 22, D-14195 Berlin, Germany. Tel.: +49 30 83 22 73 60; fax: +49 30 84 10 98 62.

Received 19 December 2008 ,Revised 19 August 2009 ,Accepted 31 August 2009.

References 

  1. Ruggeri ZM. Platelet and von Willebrand factor interactions at the vessel wall. Hamostaseologie. 2004;24:1–11
  2. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996;84:289–297
  3. Matsushita T, Dong Z, Sadler JE. Von Willebrand's factor and von Willebrand's disease. Curr Opin Hematol. 1994;1:362–368
  4. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:359–424
  5. Dong J-F. Cleavage of ultra-large von Willebrand factor by ADMATS-13 under flow conditions. J Thromb Haemost. 2005;3:1710–1716
  6. Slayter H, Loscalzo J, Bockenstedt P, Handin RI. Native conformation of human von Willebrand protein. Analysis by electron microscopy and quasi-elastic light scattering. J Biol Chem. 1985;260:8559–8563
  7. Kang I, Raghavachari M, Hofmann CM, Marchant RE. Surface-dependent expression in the platelet GPIb binding domain within human von Willebrand factor studied by atomic force microscopy. Thromb Res. 2007;6:731–740
  8. Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, Marchant RE. Shear dependent changes in the three-dimensional structure of human von Willebrand factor. Blood. 1996;88:2939–2950
  9. Kehrel B. Platelet-collagen interactions. Semin Thromb Hemost. 1995;21:123–129
  10. Saelman EU, Nieuwenhuis HK, Hese KM, de Groot PG, Heijnen HF, Sage EH, et al. Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIα (α2β1-integrin). Blood. 1993;83:1244–1250
  11. Sixma JJ, van Zanten GH, Saelman EUM, Verkleij M, Lankhof H, Nieuwenhuis HK, et al. Platelet adhesion to collagen. Thromb Haemost. 1995;74:454–459
  12. Li F, Moake JL, McIntire LV. Characterization of von Willebrand factor interaction with collagens in real time using surface plasmon resonance. Ann Biomed Eng. 2002;30:1107–1116
  13. Fischer BE, Thomas KB, Dorner F. Von Willebrand factor: measuring its antigen or function? Correlation between the level of antigen, activity, and multimer size using various detection systems. Thromb Res. 1998;91:39–43
  14. Zwaginga JJ, Sakariassen KS, King MR, Diacovo TG, Grabowski EF, Nash G, et al. Can blood flow assays help to identify clinically relevant differences in von Willebrand factor functionality in von Willebrand disease types 1–3?. J Thromb Haemost. 2007;5:2547–2549
  15. Stadler M, Gruber G, Kannicht C, Biesert L, Radomski KU, Suhartono H, et al. Characterisation of a novel high purity, double virus inactivated von Willebrand factor and factor VIII concentrate Wilate. Biologicals. 2006;34:281–288
  16. Tangelder GJ, Slaaf DW, Arts T, Reneman RS. Wall shear rate in arterioles in vivo: least estimates from platelet velocity profiles. Am J Physiol. 1988;254:H1059–H1064
  17. Stroev PV, Hoskins PR, Easson WJ. Distribution of wall shear rate throughout the arterial tree: A case study. Atherosclerosis. 2007;191:276–280
  18. Budde U, Pieconka A, Will K, Schneppenheim R. Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification. Semin Thromb Hemost. 2006;32:514–521
  19. Vollmar B, Slotta JE, Nickels RM, Wenzel E, Menger MD. Comparative analysis of platelet isolation techniques for the in vivo study of the microcirculation. Microcirculation. 2003;10:143–152
  20. Vanhoorelbeke K, Depraetere H, Romijin RAP, Huizinga EG, De Maeyer M, Deckmyn H. A consensus tetrapeptide selected by phage display adopts the conformation of a dominant discontinuous epitope of a monoclonal anti-VWF antibody that inhibits the von Willebrand factor-collagen interaction. J Biol Chem. 2003;278:37815–37821
  21. Moroi M, Jung SM, Shinmyozu K, Tomiyama Y, Ordinas A, Diaz-Ricart M. Analysis of platelet adhesion to a collagen-coated surface under flow conditions: the involvement of glycoprotein VI in the platelet adhesion. Blood. 1996;88:2081–2092
  22. Baumgartner HR, Haudenschild C. Adhesion of platelets to subendothelium. Ann NY Acad Sci. 1972;201:22–36
  23. Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc Res. 1973;5:167–179
  24. Sakariassen KS, Aarts PAMM, de Groot PG, Houdijk WPM, Sixma JJ. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix and purified components. J Lab Clin Med. 1983;102:522–535
  25. Bonnefoy A, Yamamoto H, Thys C, Kito M, Vermylen J, Hoylaerts MF. Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha. Blood. 2003;10:1375–1383
  26. Zwaginga JJ, Sakariassen KS, Nash G, King MR, Heemskerk JWM, Frojmovic M, et al. Flow-based assays for global assessment of haemostasis. Part 2: Current methods and considerations for the future. J Thromb Haemost. 2006;4:2716–2717
  27. Chand S, McCraw A, Hutton R, Tuddenham EG, Goodall AH. A two-site, monoclonal antibody-based immunoassay for von Willebrand factor-demonstration that VWF function resides in a conformational epitope. Thromb Haemost. 1986;55:318–324
  28. Murdock PJ, Woodhams BJ, Matthews KB, Pasi KJ, Goodall AH. Von Willebrand factor activity detected in a monoclonal antibody-bases ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use. Thromb Haemost. 1997;78:1272–1277
  29. Godall AH, Jarvis J, Chand S, Rawlings E, O'Brien DP, McGraw A, et al. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope. B J Haemat. 1985;59:565–577
  30. Wu YP, van Breugel HH, Lankhof H, Wise RJ, Handin RI, de Groot PG, et al. Platelet adhesion to multimeric and dimeric von Willebrand factor and to collagen type III preincubated with von Willebrand factor. Arterioscler Thromb Vasc Biol. 1996;16:611–620
  31. Savage B, Sixma JJ, Ruggeri ZM. Functional self-association of von Willebrand factor during platelet adhesion under flow. Proc Natl Acad Sci U S A. 2002;99:425–430
  32. Barg A, Ossig R, Goerge T, Schneider MF, Schillers H, Oberleithner H, et al. Soluble plasma-derived von Willebrand factor assembles to a haemostatically active filamentous network. Thromb Haemost. 2007;97:514–526
  33. Wu D, Vanhoorelbeke K, Cauwenberghs N, Meiring M, Depraetere H, Kotze HF, et al. Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons. Blood. 2002;99:3623–3628
  34. Bernardo A, Bergeron AL, Sun CW, Guchhait P, Cruz MA, Lopez JA, et al. Von Willebrand factor present in fibrillar collagen enhances platelet adhesion to collagen and collagen-induced platelet aggregation. J Thromb Haem. 2003;2:660–669
  35. Watson HG, Greaves M. Can we predict bleeding?. Semin Thromb Hemost. 2008;34:97–103
  36. Hoylaerts MF. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor. Verh K Acad Geneeskd Belg. 1997;59:161–183
  37. Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, et al. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease. Clin Appl Thromb Hemost. 2006;12:397–420

PII: S0049-3848(09)00396-X

doi: 10.1016/j.thromres.2009.08.020

Thrombosis Research
Volume 125, Issue 3 , Pages 239-245 , March 2010

Article Tools

* Image Usage & Resolution